Posted in | News | Graphene

The First Highway Trials Show That Nanotube-Reinforced Asphalt Concrete Prevents Cracks and Ruts

Trials of the world’s first experimental section of road pavement with graphene nanotubes have demonstrated a 67% increase in resistance to rutting and cracking. The next step in the industrial application of the technology is designing a road network with a nanotube-reinforced pavement.

The Russian company ECO Group has successfully tested road bitumen modified with TUBALL graphene nanotubes produced by OCSiAl. The Ministry of Transport of the Russian Federation had found the formulation to be promising and thus authorized an experimental section of road pavement with nanotubes to be laid on the M-4 Don federal highway.

“Graphene nanotubes form a reinforcing network in asphalt concrete, which improves its physical and mechanical properties: rutting resistance, ring-and-ball softening point, ultimate compressive strength, and fatigue life,” says Alexander Zimnyakov, OCSiAl’s Vice President. “This significantly boosts asphalt concrete’s performance, which is especially important for roads subjected to intense traffic loads at high temperatures.”

Nanotubes are introduced into bitumen using adhesive agents, and the modified bitumen is then added to asphalt concrete. Nanotubes improve the properties of road bitumen even at very low concentrations, from 0.025% to 0.035% in the total weight of bitumen, while the content of bitumen itself in asphalt concrete does not exceed 6%. The tests showed an increase in the softening point by 10 °C and a more than twofold increase in the viscosity of the binding agent.

As a result, asphalt concretes containing bitumen with TUBALL nanotubes demonstrate a 67% improvement in rutting resistance and a 67.5% boost in fatigue cracking resistance.

Now, after these successful trials, the next step in the nationwide application of this invention involves designing a road network with a nanotube-reinforced pavement.

“The Expert Council under the Ministry of Transport of the Russian Federation, with the participation of experts from various ministries and departments, recognized the innovative nature of ECO Group’s asphalt concrete modification, approved its application in road construction, and recommended considering its use in road construction,” said ECO Group’s General Director, Alexander Greiz.

Graphene nanotubes (also known as single wall carbon nanotubes) are an incredibly strong and light material that is widely used to change the properties of various materials. Their ability to improve asphalt concrete pavements is being researched by teams of scientists around the world. This solution is one of the first to be green-lighted for testing on real roads.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    OCSIAL Group. (2020, January 17). The First Highway Trials Show That Nanotube-Reinforced Asphalt Concrete Prevents Cracks and Ruts . AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=37106.

  • MLA

    OCSIAL Group. "The First Highway Trials Show That Nanotube-Reinforced Asphalt Concrete Prevents Cracks and Ruts ". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=37106>.

  • Chicago

    OCSIAL Group. "The First Highway Trials Show That Nanotube-Reinforced Asphalt Concrete Prevents Cracks and Ruts ". AZoNano. https://www.azonano.com/news.aspx?newsID=37106. (accessed November 21, 2024).

  • Harvard

    OCSIAL Group. 2020. The First Highway Trials Show That Nanotube-Reinforced Asphalt Concrete Prevents Cracks and Ruts . AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=37106.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.